Psoriatic Arthritis during Treatment with Bevacizumab for Anaplastic Oligodendroglioma
Bevacizumab is a recombinant humanised monoclonal antibody directed against the vascular endothelial growth factor (VEGF). The drug, alone or in combination with other anticancer agents, has been shown to be effective against several types of neoplasms. We report a case of a woman with a history of...
Saved in:
| Main Authors: | D. Graceffa, E. Maiani, A. Pace, F. M. Solivetti, F. Elia, C. De Mutiis, C. Bonifati |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2012/208606 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMBINED CHEMOTHERAPY INCLUDING PROCARBAZINE (NATULAN) IN THE TREATMENT OF ANAPLASTIC OLIGODENDROGLIOMAS
by: D. R. Naskhletashvili, et al.
Published: (2015-04-01) -
The Impact of Social Determinants of Health on the Diagnosis of Anaplastic Oligodendroglioma: A Case Report
by: Meghan Acheson, et al.
Published: (2025-03-01) -
IS PSORIATIC ARTHRITIS REALLY PSORIATIC?
by: Sh. F. Erdes
Published: (2014-12-01) -
Imunoistoquímica em oligodendrogliomas
by: Arlete Hilbig
Published: (2006-03-01) -
Ixekizumab in the treatment of psoriatic arthritis
by: Yu. L. Korsakova, et al.
Published: (2024-12-01)